Jacinda B. Sampson, MD, PhD
Assistant Professor of Neurology
Clinical Director, Neurogenetics Program
email: js4171@columbia.edu
Education:
American Board of Psychiatry & Neurology (Neurology)
Office Location:
The Neurological Institute of New York
710 West 168th Street
New York, New York 10032
Office Telephone: 212-305-1303
Insurance: Aetna, Healthfirst, Healthplus/Amerigroup, Multiplan, Neighborhood Health Providers, NYS Medicaid
*Please verify insurance participation with the physician's office when making an appointment.
Assistant Professor of Neurology
Clinical Director, Neurogenetics Program
email: js4171@columbia.edu
Education:
- BA: St. Mary's College of Maryland
- MD & PhD: University of Alabama at Birmingham
- Internship: University of Utah School of Medicine
- Residency: University of Utah School of Medicine, Neurology
American Board of Psychiatry & Neurology (Neurology)
Office Location:
The Neurological Institute of New York
710 West 168th Street
New York, New York 10032
Office Telephone: 212-305-1303
Insurance: Aetna, Healthfirst, Healthplus/Amerigroup, Multiplan, Neighborhood Health Providers, NYS Medicaid
*Please verify insurance participation with the physician's office when making an appointment.
» Department of Neurology
» Recent Publications
As Clinical Director of the multidisciplinary Neurogenetics Program, Dr. Sampson cares for patients and families with a variety of disorders including hereditary ataxias, hereditary spastic paraparesis, familial chorea (including McLeod's neuroacanthocytosis), oculodentodigital dysplasia, neurofibromatosis, tuberous sclerosis, CADASIL and other familial early onset stroke, as well as other familial neurological disorders. She offers transitional care for adults with neurogenetic disorders diagnosed in childhood. She also offers testing* and care for adult family members at risk for neurogenetic disorders diagnosed in a pediatric family member.
Dr. Sampson also sees patients in the Eleanor and Lou Gehrig MDA/ALS Multidisciplinary Care Center, where her expertise includes the diagnosis and care of individuals with myotonic dystrophy type 1 and 2, amyotrophic lateral sclerosis, limb-girdle myopathies, metabolic and mitochondrial myopathies, Duchenne and Becker muscular dystrophy, Friedreich's ataxia, periodic paralysis, and Charcot-Marie Tooth neuropathies.
In research, Dr. Sampson is currently focused on discovering the genetic basis of familial restless legs syndrome (Willis-Ekbom disease). She is interested in using exome and genome sequencing to identify new genes associated with neurogenetic disorders, in either single or phenotypically similar families. One such project, in progress, is identifying a genetic cause of cerebroretinovasculopathy.
* Genetic testing for neurogenetic disorders involves diagnostic guidance, genetic counseling, interpretation of results and their validity, education of the patient and family, and care recommendations.
© 2012 The Neurological Institute of New York • 710 W 168th St, New York, NY 10032
Department of Neurology | Columbia University Medical Center | Last updated: December 4, 2012 | Comments